-
Amedisys (AMED) PT Raised to $150 at RBC Capital
-
Amedisys to Present at the 2019 RBC Capital Markets Healthcare Conference
-
Amedisys (AMED) PT Raised to $133 at RBC Capital
-
Amedisys (AMED) PT Raised to $126 at RBC Capital
-
Amedisys (AMED) PT Raised to $115 at RBC Capital
-
UPDATE: RBC Capital Upgrades Amedisys (AMED) to Outperform, Sees Attractive Setup for 2018 and Beyond
-
Notable Analyst Rating Changes 6/9: (ECR) (AMED) (NBL) Upgraded; (CTXS) (ALV) (AKAM) Downgraded
-
RBC Capital Upgrades Amedisys (AMED) to Sector Perform
-
RBC Capital Downgrades Amedisys (AMED) to Underperform
-
RBC Cuts LHC Group (LHCG), Almost Family (AFAM) to Sector Perform Following Soft Amedisys Outlook
-
Notable Analyst Rating Changes 8/26: STJ, GMR, KMT, CP Upgraded; BKC, AMED, MDAS Downgraded
-
Notable Analyst Rating Changes 8/19: MA, DKS, AFFY Upgraded; DRI, ADP, BIOF Downgraded
-
RBC Capital Initiates Coverage on Amedisys (AMED) with an Outperform

